Cheng Chun-Han, Hao Wen-Rui, Cheng Tzu-Hurng
Department of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan.
Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, Taipei 23561, Taiwan.
World J Radiol. 2024 Sep 28;16(9):375-379. doi: 10.4329/wjr.v16.i9.375.
Contrast-induced acute kidney injury (CI-AKI) is a major concern in clinical practice, particularly among high-risk patients with preexisting renal and cardiovascular conditions. Although periprocedural hydration has long been the primary approach for CI-AKI prevention, recent advancements have led to the development of novel approaches such as RenalGuard and contrast removal systems. This editorial explores these emerging approaches and highlights their potential for enhancing CI-AKI prevention. By incorporating the latest evidence into clinical practice, health-care professionals can more effectively maintain renal function and improve outcomes for patients undergoing contrast-enhanced procedures.
对比剂诱导的急性肾损伤(CI-AKI)是临床实践中的一个主要关注点,尤其是在患有肾脏和心血管疾病的高危患者中。尽管围手术期水化长期以来一直是预防CI-AKI的主要方法,但最近的进展导致了诸如RenalGuard和对比剂清除系统等新方法的开发。这篇社论探讨了这些新兴方法,并强调了它们在增强CI-AKI预防方面的潜力。通过将最新证据纳入临床实践,医疗保健专业人员可以更有效地维持肾功能,并改善接受对比剂增强检查的患者的预后。